FIRST LINE BE-WEEKLY REGIMEN WITH DOCETAXEL AND GEMCITABINE IN HER-2 NEGATIVE AND ANTRACYCLINE-PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS: PRELIMINARY RESULTS OF A MULTICENTER PHASE II TRIAL
ANNALS OF ONCOLOGY（2009）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要